In accordance with the Food and Drug Safety Administration's change order for drug manufacturing (import) product approval (Permission Review and Coordination Division-No. 2196, effective date 2010.05.07), the precautions for use of Lamiryl tablets have been changed.
 


For further details, please refer to the ‘Product Introduction’ section and attached documents.